Home
This site is intended for healthcare professionals

Obstructive Sleep Apnea Care Pathways Translating Cardiometabolic Risk into Longitudinal Management: Module 4 Sustained Management

Share

Description

This activity is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals in the U.S.

Dr. Kirsch provides a practical, longitudinal framework for the long-term management of OSA, emphasizing the need to treat airway obstruction and obesity as interconnected clinical targets. This module focuses on troubleshooting early physical and psychological barriers to positive airway pressure (PAP) therapy and scheduling proactive, shared follow-ups to maintain patient adherence and improve cardiometabolic metrics over time.

Session Highlights

  • Implement a longitudinal care framework that integrates airway-directed therapies with continuous tracking of cardiometabolic metrics, including weight trajectory, blood pressure, and glycemic control.
  • Troubleshoot early barriers to positive airway pressure (PAP) therapy by scheduling 2-to-6-week checks to resolve equipment fit, dryness, or anxiety before patients abandon treatment.

Prefer to watch in Spanish? Click Here

Who Should Participate?

This program is designed for healthcare professionals who seek to incorporate structured OSA screening and diagnostic activation into routine cardiometabolic management workflows.

  • Primary Care Physicians and Family Medicine Practitioners
  • Nurse Practitioners
  • Physician Assistants

This is Module Four of Six, See Modules 1, 2, 3, 5 and 6 Here.

Prefer to read? See our Key Clinical Summary Here.

Faculty

Dr Douglas Kirsch

Dr Douglas Kirsch is Medical Director of Sleep Medicine at Atrium Health and a Professor of Internal Medicine and Neurology. A board-certified sleep medicine specialist, he has extensive expertise in the diagnosis and management of sleep disorders, with a particular research focus on obstructive sleep apnea. His research examines the impact of OSA treatment on patient hospitalizations and explores the use of consumer wearable devices to assess sleep in the home setting. Dr Kirsch is a former President of the American Academy of Sleep Medicine and is dedicated to improving sleep health and patient well-being.

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Dr Douglas Kirsch, faculty for this educational activity, has the following relevant financial relationships: Scientific Advisory Board Apnimed, Incannex, Huxley Medical. Expert Panel Carelon. Consulting ResMed.

The MedAll staff, program planners, and reviewers have no relevant financial relationships with ineligible companies to disclose.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associate Continuing Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 ANCC contact hours.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information

There is no fee for this educational activity.

This continuing education activity is active starting September 11th 2026, and will expire on July 1st 2028.

Learning objectives

1: Evaluate the bidirectional relationship between obesity and OSA to inform cardiometabolic risk assessment, demonstrating accurate identification of OSA risk within ≥75% of post-activity case-based assessments.

2: Identify patients at increased risk of OSA using clinical features and comorbidities in primary care, achieving appropriate risk stratification in ≥75% of applied clinical scenarios.

3: Apply workflow-compatible screening and triage strategies to support early identification of OSA, demonstrating correct use of structured tools and decision pathways in ≥75% of simulation-based exercises.

4: Select appropriate diagnostic and referral pathways, including HSAT, based on clinical presentation and practice context, achieving appropriate pathway activation in ≥75% of case-based assessments.

5: Apply longitudinal management and treatment progression strategies in OSA care planning to support sustained disease control, demonstrating appropriate decision-making in ≥70% of longitudinal case exercises.

6: Apply contextually adapted care strategies that account for socioeconomic and practice-setting factors to support equitable diagnostic and management decisions in OSA, demonstrating appropriate decision-making in ≥70% of applied scenarios.

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

This next section is on sustained management of patients with obstructive sleep apnea. So we've talked about evaluating the potential for patients to have sleep apnea. We've talked about how you assess patients for sleep apnea with sleep studies, and now we're going to talk about treating patients and how you do that in the long term. So it's important to recognize that when you see patients, you have to manage two sides of the spectrum. One is how am I managing their sleep apnea and whether that's with CPAP or PAP therapy, but also with other possibilities such as positional therapy, surgical options, or oral appliances. And you sometimes have to deal in patients who are obese with the obesity side of this and their cardio metabolic care, so their weight, their BP, their Blood sugars, their cardiovascular risk. And so putting that together, you are trying to make sure you understand what are their current symptoms, how adherent are they to therapy, whether obstructive sleep apnea therapy or their um therapy for their cardio metabolic symptoms. How tolerable is that therapy? What are their goals, and what are reasons to escalate this to a higher level and potentially to have them see a specialist. So we have to manage both of these things over time as best we can knowing that time is limited. So let's talk about this a little bit and what that framework might look like. So, if you start somebody on path therapy, the most important thing is having patients understand why they are getting that treatment and why that treatment is important. Too often patients do not get told why they need a CPAP machine, and they are much less likely to use a CPAP machine if they don't understand the reasoning for it. So explaining to patients why they need a machine and why it's important to use it is a first step towards success. And then the second most important part is the education around getting the machine and the early follow-up. So when they get a machine, helping them understand how to select the right kind of CPAP mask, what the pressure settings should be on their CPAP machine. And making sure they have that early support either from your clinic or from the home medical equipment company is crucial to make a patient successful because we know that if we can intervene with problems early, particularly in the 1st 2 to 4 weeks, a patient is much more likely to be adherent in the long run than if they don't come back and see somebody for 3 or 4 months, at which point they've often already given up. What are some of the things that you think about in that early phase? Well, it's about mask fit. It's about making sure that their pressure is comfortable for them, making sure that they're getting appropriate humidification from their CPAP machine, um, and that they're just using it every night. I tell patients that it is the most important thing to start every night with it. They may take it off in the middle of the night. They may struggle to keep it on. They may wake up and it's off and they don't remember taking it off. But if they start each night with it, it is much more likely that they're going to be able to get comfortable with it, particularly in that 1st 2 to 4 weeks. How do we assess how they're doing? Well, part of it is based on the patient's report of their symptoms, but part of it is also getting data back from their CPAP machine to make sure that they're using it appropriately and that it's doing what we expect it to do, that in fact their sleep apnea appears controlled. Understanding what their experience is there is crucial because even at that 3 month review, assuming you were meeting with that patient, there are still some subtle tweaks that can often be made to make that patient's experience just a little bit better and we know each click along that way that we can make that experience better is going to keep that patient on therapy longer. And then continuing to treat over time to make sure that they are doing well. This requires follow up in my clinic. It's usually we will see them back at 3 months, 6 months, and a year in the first year, and then assuming they're doing well yearly thereafter, but every clinic may do things slightly differently. So what do you do if a pap therapy isn't working for a patient? Well, the first problem is trying to figure out Whether a patient is having a problem or not, how do you do that? Well, A couple of things. One is, is a patient feeling any better? The answer may be yes or no. Um, and if the case is I'm not feeling better, are you using treatment? The second thing is, is a patient just stopped using it or using it as regularly and what has been a problem there? Sometimes patients just drop off for a few days when they get sick, but sometimes they drop off and then they never pick it back up again. And so it's important to make sure that you're tracking that data every so often. Again, hoping that you're getting some help from your uh durable medical equipment company who has provided that patient a CPAP machine. And then tracking that data to make sure that there aren't residual apnea still on. While the patient is using CPAP, that is a sign of a problem, and you want to make sure that that is being addressed. Now if that data is mildly abnormal, you might not be particularly prone to trying to make the patient much more uncomfortable on their CPAP by changing the pressure settings. On the other hand, if it's significantly abnormal, you might choose to be more aggressive about that. So, once you found that there's a problem, talk to the patient. That's the best source of the information. Is this a mask issue? Is this a pressure issue? Is this a dryness issue? Is it nasal congestion that's a problem? Are you having anxiety or difficulty sleeping with the CPAP in place? Is cost a problem? Is this gonna be an issue of, hey, I don't think this is really working for me? And sometimes they just need to give it more time. Patients often expect that this will be effective day one. And I often tell people that it can take 2 to 4 weeks just to get used to the mask and the machine, and then it may be that you don't feel better for 2 or 3 months. That's why that 3 month time frame is really important to check back in with patients. And then the question is, well, once you've identified that there's a problem and you've figured out what the problem is, now how can I fix it? Well, can you fix it yourself? Is there a barrier you can change or tweak to make that patient easier? Is that a, hey, let me just reinforce the importance of this. Let me just make sure that your settings look correct and remind you that using a machine is is an important treatment for your sleep apnea. But sometimes you're not going to be able to do that on your own, and escalating care to a sleep specialist can be helpful at this point. And that may be to reassess whether the diagnosis is a good one. Was the test a fair test of their sleep apnea initially, and are you treating the right thing? Could they have central sleep apnea? Is the CPAP a right treatment? Could they need a BiPAP machine? All these things are possible. And so making sure that you get a specialist involved in some cases can be helpful. So to summarize this slide, just make sure that once you start the process, you figure out how you can address it and then reassess after you've made a change to make sure that you've in fact the patient has found improvement from whatever you've done, whether that's from data or patient experience. These are the steps to think. If the patient has really struggled with PAP therapy and it is not an option for them at that point, would you consider other treatments of sleep apnea for them, whether that's an oral appliance, whether that's positional strategies, whether that's surgical intervention, or continuing to work on weight in a more intensive way? So weight treatment alone Can be part, should be part of sleep apnea care in those who are obese. And so we know that as we drop weight in patients, that their AHI is likely to improve, as you can see in the graph here on the slide. The more weight they lose, the lower the AHI tends to be. Now just because somebody has lost weight doesn't mean that their sleep apnea is necessarily resolved. And so it is important to consider once somebody has stabilized at a new weight to reassess the situation from a sleep apnea severity perspective. How do you get that weight to be uh lower? Well, I would say a few things. One, Working with patients on diet and exercise has been a classic part of visits for patients for years. But again, sometimes you can't do this on your own. And whether that's working with a dietitian or nutritionist, whether that's working with behavioral health, whether it's looking at pharma uh pharma the pharmacology of the drugs that they are currently on, or whether a new drug needs to be added, or whether there's a bariatric pathway that is important for that patient and working with weight management.